OTCPK:WLYY.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. More Details


Snowflake Analysis

Adequate balance sheet and slightly overvalued.

Share Price & News

How has WELL Health Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: WLYY.F's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

9.0%

WLYY.F

1.6%

US Healthcare

1.0%

US Market


1 Year Return

323.0%

WLYY.F

15.9%

US Healthcare

13.6%

US Market

Return vs Industry: WLYY.F exceeded the US Healthcare industry which returned 15.9% over the past year.

Return vs Market: WLYY.F exceeded the US Market which returned 13.6% over the past year.


Shareholder returns

WLYY.FIndustryMarket
7 Day9.0%1.6%1.0%
30 Day33.1%-4.4%-0.4%
90 Day165.3%1.1%8.9%
1 Year323.0%323.0%17.4%15.9%16.2%13.6%
3 Yearn/a29.1%23.4%40.2%30.8%
5 Yearn/a52.8%42.1%89.6%68.2%

Price Volatility Vs. Market

How volatile is WELL Health Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is WELL Health Technologies undervalued compared to its fair value and its price relative to the market?

36.7%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: WLYY.F ($5.2) is trading below our estimate of fair value ($8.22)

Significantly Below Fair Value: WLYY.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: WLYY.F is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: WLYY.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate WLYY.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: WLYY.F is overvalued based on its PB Ratio (17.1x) compared to the US Healthcare industry average (2.9x).


Next Steps

Future Growth

How is WELL Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

66.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: WLYY.F is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: WLYY.F is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: WLYY.F is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: WLYY.F's revenue (34.1% per year) is forecast to grow faster than the US market (9.7% per year).

High Growth Revenue: WLYY.F's revenue (34.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if WLYY.F's Return on Equity is forecast to be high in 3 years time


Next Steps

  • Explore growth companies in the Healthcare industry.

Past Performance

How has WELL Health Technologies performed over the past 5 years?

-60.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: WLYY.F is currently unprofitable.

Growing Profit Margin: WLYY.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: WLYY.F is unprofitable, and losses have increased over the past 5 years at a rate of 60.9% per year.

Accelerating Growth: Unable to compare WLYY.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: WLYY.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).


Return on Equity

High ROE: WLYY.F has a negative Return on Equity (-18.86%), as it is currently unprofitable.


Next Steps

Financial Health

How is WELL Health Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: WLYY.F's short term assets (CA$28.9M) exceed its short term liabilities (CA$10.8M).

Long Term Liabilities: WLYY.F's short term assets (CA$28.9M) exceed its long term liabilities (CA$25.6M).


Debt to Equity History and Analysis

Debt Level: WLYY.F's debt to equity ratio (21.5%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if WLYY.F's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: WLYY.F has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if WLYY.F has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is WELL Health Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate WLYY.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate WLYY.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if WLYY.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if WLYY.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of WLYY.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

Hamed Shahbazi (45 yo)

2.33yrs

Tenure

Mr. Hamed Shahbazi, B.Sc serves as a Director at Hire Technologies Inc. (formerly known as Bay Talent Group Inc.) (formerly known as Danacore Industries Inc.). He is Founder of WELL Health Technologies Cor ...


Leadership Team

NamePositionTenureCompensationOwnership
Hamed Shahbazi
Founder2.33yrsno data9.21%
CA$ 64.2m
Eva Fong
Chief Financial Officer1.42yrsCA$103.33k0.58%
CA$ 4.0m
Amir Javidan
Chief Operating Officer1.67yrsCA$39.39k2.14%
CA$ 14.9m
Brian Levinkind
Senior Vice President of Corporate Development1.42yrsCA$216.00kno data
Arjun Kumar
Chief Information Officer1.17yrsno data2.15%
CA$ 15.0m
Pardeep Sangha
VP of Corporate Strategy & Investor Relations1.42yrsno datano data
Chris Ericksen
Senior Vice President of Strategic Partnerships & Marketing1.67yrsno datano data
Makiko Deniz
HR & Office Manager1.67yrsno datano data
Michael Frankel
Chief Medical Officer1.83yrsno datano data
Sara Bond
Senior Vice President of Product Development1.67yrsno datano data
Michael Goodman
Head of Acquisitions - Eastern Canada0.17yrno datano data

1.7yrs

Average Tenure

Experienced Management: WLYY.F's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Hamed Shahbazi
Founder2.33yrsno data9.21%
CA$ 64.2m
Thomas Liston
Independent Director2.42yrsno data0.33%
CA$ 2.3m
Kenneth Cawkell
Independent Director4.5yrsno data0.11%
CA$ 787.0k
John Kim
Independent Director2.58yrsno data0.44%
CA$ 3.1m
Patricia Kirkpatrick
Member of Advisory Board1yrno datano data
Tara McCarville
Independent Director0.42yrno datano data

2.4yrs

Average Tenure

Experienced Board: WLYY.F's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.8%.


Top Shareholders

Company Information

WELL Health Technologies Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: WELL Health Technologies Corp.
  • Ticker: WLYY.F
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$918.162m
  • Listing Market Cap: CA$697.114m
  • Shares outstanding: 132.87m
  • Website: https://www.well.company

Number of Employees


Location

  • WELL Health Technologies Corp.
  • 322 Water Street
  • Suite 200
  • Vancouver
  • British Columbia
  • V6B 1B6
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
WELLTSX (The Toronto Stock Exchange)YesCommon SharesCACADJun 2017
W7VDB (Deutsche Boerse AG)YesCommon SharesDEEURJun 2017
WLYY.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJun 2017

Biography

WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. The company also provides digital electronic medical records (EMR) software services; and telehealth services. ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/19 05:49
End of Day Share Price2020/09/18 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.